9 Best Performing European Stocks to Invest In

6. BeOne Medicines Ltd. (NASDAQ:ONC)

Year-to-Date Performance: 100.69%

Number of Hedge Fund Holders: 28

BeOne Medicines Ltd. (NASDAQ:ONC) ranks among the best-performing European stocks to invest in. On August 29, BeOne Medicines Ltd. (NASDAQ:ONC) stated that the Phase 1/2 research of sonrotoclax had reached its main objective of overall response rate in patients with relapsed or refractory mantle cell lymphoma.

The trial showed clinically relevant responses in the extensively pretreated patient category. Promising outcomes were also observed for secondary goals, including progression-free survival, response duration, and a complete response rate.

BeOne Medicines Ltd. (NASDAQ:ONC) plans on sending the data for possible approval to the U.S. Food and Drug Administration as well as other international regulatory agencies. The company has already filed new drug applications with China’s National Medical Products Administration for sonrotoclax in chronic lymphocytic leukemia and relapsed or refractory mantle cell lymphoma.

BeOne Medicines Ltd. (NASDAQ:ONC) is a global biotechnology company that specializes in oncology medicines, particularly for blood cancers and solid tumors.